Rheumatoid Arthritis and OsteoarthritisCME Physicians - up to 2.0 hour(s) of AMA PRA category 1 credit; Registered Nurses - up to 2.4 Nursing Continuing Education contact hour(s) Update on Current Therapies for Rheumatoid Arthritis Stanley B. Cohen, MD Therapies for Rheumatoid Arthritis Under Development Stanley B. Cohen, MD Clinical Advances in Osteoarthritis Lee S. Simon, MD More...
Osteoporosis and GoutCME Physicians - up to 1.0 hour(s) of AMA PRA category 1 credit; Registered Nurses - up to 1.2 Nursing Continuing Education contact hour(s) Advances in Osteoporosis Michael C. Nevitt, PhD New Developments in Gouty Arthritis I. Jon Russell, MD, PhD
SLE, Fibromyalgia, and Sjögren's SyndromeCME Physicians - up to 1.0 hour(s) of AMA PRA category 1 credit; Registered Nurses - up to 1.2 Nursing Continuing Education contact hour(s) Key Findings in Systemic Lupus Erythematosus, Sjögren's Syndrome, and Myositis Robert I. Fox, MD, PhD New Developments in the Management of Fibromyalgia Syndrome I. Jon Russell, MD, PhD
Infliximab Improves Symptoms of Psoriatic Arthritis10/28/02 At week 10, 82% of patients taking 5 mg/kg infliximab and 73% of those taking 10 mg/kg achieved at least a 75% improvement from baseline in the PASI score.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the American College of Rheumatology. These materials and the related activity are not sanctioned by the American College of Rheumatology or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not reflect the views of Medical Education Collaborative, Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing medical education activity.
Update on Current Therapies for Rheumatoid Arthritis